Cellcept and Garamycin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cellcept (mycophenolate mofetil) and Garamycin (gentamicin sulfate). Common drug interactions include central pontine myelinolysis among females.

The phase IV clinical study analyzes what interactions people have when they take Cellcept and Garamycin. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Cellcept?

Cellcept has active ingredients of mycophenolate mofetil. It is often used in systemic lupus erythematosus. eHealthMe is studying from 41,872 Cellcept users. Check the latest studies of Cellcept.

What is Garamycin?

Garamycin has active ingredients of gentamicin sulfate. eHealthMe is studying from 440 Garamycin users. Check the latest studies of Garamycin.

On Jul, 18, 2026

11 people who take Cellcept and Garamycin together, and have interactions are studied.

Cellcept and Garamycin drug interactions.

What are the common drug interactions of Cellcept and Garamycin, by gender? *:

female:

Central pontine myelinolysis (severe damage of nerve cells in brain)
Convulsions (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled of muscles contract and relax rapidly and repeatedly)
Blood pressure decreased
Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
Contusion (a type of hematoma of tissue in which capillaries)
Dyskinesia (abnormality or impairment of voluntary movement)
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
Hyperglycaemia (high blood sugar)
Multi-organ failure (multisystem organ failure)
Neutropenia (an abnormally low number of neutrophils)

male:

n/a

What are the common drug interactions of Cellcept and Garamycin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Acute leukaemia (blood cancer)
Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
Alopecia (absence of hair from areas of the body)
Anal fissure
Atelectasis (partial or complete collapse of the lung)
Blood pressure decreased
Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
Contusion (a type of hematoma of tissue in which capillaries)
Hyperglycaemia (high blood sugar)

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Central pontine myelinolysis (severe damage of nerve cells in brain)
Convulsions (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled of muscles contract and relax rapidly and repeatedly)
Demyelination (loss of the myelin covering of some nerve fibres resulting in their impaired function)
Discomfort
Hypertonia (abnormal increase in muscle tension and a reduced ability of a muscle to stretch)
Partial seizures (seizures which affect only a part of the brain at onset)
Speech disorder
Muscle spasticity (tight or stiff muscles and an inability to control those muscles)
Dyskinesia (abnormality or impairment of voluntary movement)
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 2 people, 18.18%
Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Cellcept and Garamycin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously